Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results
Select data models

Selected data models

You must log in to select data models for download or further analysis.

1 Search results.

Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198 - Eligibility criteria

- 4/8/19 - 1 form, 3 itemgroups, 22 items, 1 language

Itemgroups: Administrative data, Inclusion Criteria, Exclusion Criteria

Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the eligibility criteria. It has to be filled in for screening.

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial

Keywords

Table of contents

Selected data models

Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198 - Eligibility criteria

Keywords

Table of contents

Selected data models

Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198 - Eligibility criteria

Contact

Help